You just read:

Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients

News provided by

Astellas Pharma US, Inc.

Dec 10, 2013, 07:00 ET